Cleared Traditional

K041841 - PACHYCAM

K041841 is an FDA 510(k) clearance for PACHYCAM, manufactured by Oculus Optikgerate GmbH. The device is a Class 2 Ophthalmic device with product code MXK cleared through the Traditional 510(k) pathway after a 204-day FDA review.

K041841 · Oculus Optikgerate GmbH · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2005
Decision
204d
Days
Class 2
Risk

K041841 is an FDA 510(k) clearance for the PACHYCAM. Classified as Device, Analysis, Anterior Segment (product code MXK), Class II - Special Controls.

Submitted by Oculus Optikgerate GmbH (Wetzla-Dutenhofen, DE). The FDA issued a Cleared decision on January 28, 2005 after a review of 204 days - an extended review cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.1850 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Ophthalmic review framework, consistent with the majority of Class II 510(k) submissions.

View all Oculus Optikgerate GmbH devices

FDA 510(k) Submission Details - K041841

510(k) Number K041841 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 08, 2004
Decision Date January 28, 2005
Days to Decision 204 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
94d slower than avg
Panel avg: 110d · This submission: 204d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MXK Device Classification - Class 2, Special Controls

Product Code MXK Device, Analysis, Anterior Segment
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.1850
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - MXK Device, Analysis, Anterior Segment

All 14
Devices cleared under the same product code (MXK) and FDA review panel - the closest regulatory comparables to K041841.
ARGOS
K191051 · Santec Corporation · May 2019
Pentacam AXL
K152311 · Oculus Optikgerate GmbH · Jan 2016
ARGOS
K150754 · Santec Corporation · Oct 2015
HEIDELBERG RETINA TOMOGRAPH II / ROSTOCK CORNEA MODULE (HRT II / RCM)
K042742 · Heidelberg Engineering · Oct 2004
ANTERIOR EYE-SEGMENT ANALYSIS SYSTEM
K991284 · Nidek, Inc. · Aug 1999
ORBSCAN
K984443 · Technolas Perfect Vision GmbH · Mar 1999